Optimizing treatment strategies for intermediate-to-high risk pulmonary embolism

Int J Cardiol. 2023 Nov 1:390:131212. doi: 10.1016/j.ijcard.2023.131212. Epub 2023 Jul 26.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Pulmonary Embolism* / diagnosis
  • Pulmonary Embolism* / drug therapy
  • Thrombolytic Therapy
  • Treatment Outcome

Substances

  • Fibrinolytic Agents